Global Hemophilia A and B Industry Drug Forecast

1
PharmaPoint Hemophilia A and B Argentina Drug
Forecast and Market Analysis to 2022byGlobalData

• Explore all reports for  Hematology Therapeutics
  market
• _at_
• http//www.rnrmarketresearch.com/reports/life-scie
  nces/pharmaceuticals/therapeutics/hematology-thera
  peutics .

2
PharmaPoint Hemophilia A and B Argentina Drug
Forecast and Market Analysis to 2022

• The competitive landscape of hemophilia A and B
  recombinant therapy in the US and 5EU is
  dominated by the use of recombinant FVIII and FIX
  replacement factors, and patients with severe
  forms of the disease receive frequent
  prophylactic infusions beginning from the first
  one or two years of life and often continuing
  through adulthood. However, the burden on
  patients and their families to maintain the
  prophylactic treatment schedule is high, and
  there is a significant unmet need for new
  therapies that can reduce the number of weekly
  prophylactic infusions and alleviate some of this
  treatment burden.
• Argentina ranks fourth among pharmaceutical
  markets in Latin America. According to primary
  research, the majority of Argentine hemophilia
  patients have access to recombinant FVIII and RIX
  products through private insurance plans or
  through the national social security program.
  However, the national insurance program only
  covers on-demand treatment and plasma-derived
  concentrates.
• Inquire for Discount _at_
• http//www.rnrmarketresearch.com/contacts/discount
  ?rname141247 .

3
PharmaPoint Hemophilia A and B Argentina Drug
Forecast and Market Analysis to 2022

• Scope
• Overview of Hemophilia A and B including
  epidemiology, etiology, symptoms, diagnosis,
  pathology and treatment guidelines as well as an
  overview on the competitive landscape.
• Detailed information on the key drugs in
  Argentina including product description, safety
  and efficacy profiles as well as a SWOT analysis.
• Sales forecast for the top drugs in Argentina
  from 2012-2022.
• Analysis of the impact of key events as well the
  drivers and restraints affecting Argentina
  Hemophilia A and B market.
• Complete Report Available _at_
• http//www.rnrmarketresearch.com/pharmapoint-hemop
  hilia-a-and-b-argentina-drug-forecast-and-market-a
  nalysis-to-2022-market-report.html .

4
PharmaPoint Hemophilia A and B Argentina Drug
Forecast and Market Analysis to 2022

• Reasons to buy
• Understand and capitalize by identifying products
  that are most likely to ensure a robust return
• Stay ahead of the competition by understanding
  the changing competitive landscape for Hemophilia
  A and B
• Effectively plan your MA and partnership
  strategies by identifying drugs with the most
  promising sales potential
• Make more informed business decisions from
  insightful and in-depth analysis of drug
  performance
• Obtain sales forecast for drugs from 2012-2022 in
  Argentina
• Buy a copy of report _at_ 
• http//www.rnrmarketresearch.com/contacts/purchase
  ?rname141247 .

5
PharmaPoint Hemophilia A and B Argentina Drug
Forecast and Market Analysis to 2022

• Table of Contents
• 1 Table of Contents 41.1 List of Tables 71.2
  List of Figures 9
• 2 Introduction 102.1 Catalyst 102.2 Related
  Reports 112.3 Upcoming Related Reports 13
• 3 Disease Overview 143.1 Etiology and
  Pathophysiology 143.1.1 Etiology 143.1.2
  Pathophysiology 15
• Request Sample copy of this report _at_
• http//www.rnrmarketresearch.com/contacts/request-
  sample?rname141247 .

6
PharmaPoint Hemophilia A and B Argentina Drug
Forecast and Market Analysis to 2022

• For more details contact Mr. Priyank Tiwari
  sales_at_rnrmarketresearch.com / 18883915441

RnR Market Research RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR  Market Research library has
syndicated reports by leading market research 
publishers across the globe.